These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15923065)

  • 1. Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis.
    Sable SB; Verma I; Khuller GK
    Vaccine; 2005 Jul; 23(32):4175-84. PubMed ID: 15923065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immune recognition-based multicomponent subunit vaccines against tuberculosis.
    Sable SB; Verma I; Behera D; Khuller GK
    Eur Respir J; 2005 May; 25(5):902-10. PubMed ID: 15863650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
    Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
    Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen.
    Olsen AW; Hansen PR; Holm A; Andersen P
    Eur J Immunol; 2000 Jun; 30(6):1724-32. PubMed ID: 10898510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB; Plikaytis BB; Shinnick TM
    Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immunogenicity of a Mycobacterium tuberculosis subunit vaccine].
    Song NN; Wang BX; Shi DZ; Fu LF; Luo Y; Yu HJ; Han SB; Jiao L; Qie YQ; Wang HH; Zhang Y; Zhu BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):513-6. PubMed ID: 19954005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection.
    Parlane NA; Compton BJ; Hayman CM; Painter GF; Basaraba RJ; Heiser A; Buddle BM
    Vaccine; 2012 Jan; 30(3):580-8. PubMed ID: 22120192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.
    Zhu D; Jiang S; Luo X
    Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
    Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
    Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.